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New flown, C”“nerric<,r 
only L (8%) OF 12 Griwp B patients given thmmbetyfic 
theraw (D = O.OCW. 
Recent trials (l-5) have demonstrated that early thromboly- 
tic therapy during acute myacardial infarction reduces sub 
sequent mortality. It is unclear whether this reduction in 
mortality is solely the result of preservation of myocardial 
function or whc.her other factors such as changes in electri- 
cal stability are contributory to this finding. 
Patients with a transmural ante&x myoardial infarction 
who develop a left ventricular a.neurysm during the early 
postinfarction period have an :specially poor prognosis. 
with a I year mortality rate of 60 to SOW (6.7). More than half 
of ,hese deaths occur suddenh (63. There have been few 
reports of the e6ects of rep&ion therapy on postinfarc- 
bon ventricular arrhythmias, and no reports deal specifically 
with this group of patients. 
The aim of the current study was to evaluate the effects of 
early thrombolytic therapy an the incidence of clinical and 
induced ventricular arrhythmias in a well defined group of 
patmts with a known high risk of sudden death. Thercforc. 
we prospectively evaluated and performed ambulatory clec- 
trocardiogrsphic IECGI monitoring and elcctrophysiologic 
studies in a group of padeta with an initial transmural 
anterior myocardial infarction compbcated by left ventricu- 
lar aneurysm formation who recewed either early throm- 
bolytic therapy or routine care. 
Methods 
Patient selection. The entry point for this study was the 
identification of a left ventricular aneurysm during equilib- 
rium radionuclide aneiozraphv paformed 5 + 3 davs 0twm 
i SD) after an initial anterior wall myocardial ir;farction. 
Paticnts were enrolled between September 1985 and June 
1987. Anterior wall myocardial infarction was diagnosed if 
all of the following criteria were present: new onset of chest 
pain lasting >I h, new ECG evid&ce of transmural anterior 
wall myocardial infarction (ST segment elevation that sub- 
sequently evolved into oew pathologic Q waves in two or 
more leads W, to V,, I, aVL) and elevation in serum 
creatine kinase MB fraction. Patieots were excluded if they 
I) were in cardiogenic shock at the time of equilibrium 
radionuclide angiography, 2) had a previous nontransmural 
or trammural anterior infarction, 31 had a terminal illness. or 
4) were older than 80 years. Thirty-two patients met the 
selection criteria and comprise the study group. 
Thrombolytic therapy. The decision to treat a given pa- 
tient with a thrombolytic agent (streptokinase 11.5 million 
unit5 iotmveoously over I h or a 2S.oW unit intracoronarv 
b”!!!S foollw;ed o- , 4,OM ‘L!!odn infuriaa] 01 lrcombina~t 
tissue plaxoinogen activator [rt-PA; Genentech, largely sin- 
gle-chained; 100 mg intravenously over 6 hl) was made by 
the patient’s attending physician. Such treatment was initi- 
ated within 6 h of the development of chesl pain. and was 
followed by systemic hcparinization for 3 to 5 davs and 
aspirin therapy. All pat&s who were not given thromboly- 
tic therapy received subcutaneous heparin. but the majority 
of these padeta did not rccei~e aspirin. Patients were 
entered into the present study independent of antecedent 
therapy and only after equilibrium radionuclide angiography 
demowrated an aneurysm. 
Equilibrium radionuclidc angiograpby. Equilibrium 
radionuclide angiography was performed >36 h after myo- 
cardial infarction, as previously described (6,8). Padionu- 
elide angiograms were analyzed without knowlt:gc of clin- 
ical history. A left ventricular aneurysm was identified if all 
three of the following criteria were present: I) a discrete 
region of akinesia or dyskinesia of the left ventricle, 2) a 
discrete deformity in diaatole and syrtole. and 3) normally 
contracting myocardium ad;~,.‘ent to the area of dysfunction 
(6). 
Eiwirupbysioiogic study. i’rogrammcd stimulation was 
performed 7 to 30 days (mean I3 + 6) after infarction in the 
antiarr’hythmic drug-free state. No patient had clinical sus- 
tained ventricular tachycardia or fibrillation bcforc the elec- 
trophysiologic study. One, two and three extrastimuli were 
givsn during paced rhythm at 6W and 400 ms at both the 
right ventricular apex and outflow tract. The stimulus am- 
plitude was twice diastolic threshold, and the pulse duration 
was I ms. The end point of the omtocol was the induction of 
sustained ven!rieuiar tachycarclia or protocol completion. 
Inducible ventricular tachycardia was defined as ~5 beats of 
venlricular tachycardia and sustained ventricular tachycar- 
dia was defined as lasting at least 30 s or requiring interven- 
tion for termination. 
Patients with inducible sustained ventricular tachycardia 
received antiarrhythmic therapy guided by serial electrophy- 
siologic studies; patients who had no inducible tachycardia 
or who did not undergo electrophysiologic study did not 
receive antiarrhythmic therapy. Patients with inducible non- 
sustained ventrindar tachyc&dia were treated with an anti- 
arrhythmic agent at the discretion of their attending physi- 
cian. Because only patients without clinical sustained 
ventricular arrhythmia underwent prospective invasive elec- 
trophysiologic evaluat,on in this study, the decision was 
made at the outset of this investigation not to treat a given 
patient’s inducible ventricular tachycardia with arrhythmia 
surgery or an implantable defibrillator. Approval for this 
study was obtained fmm the Human Investigation Commit- 
tee. and all enrolled patients gave infomted consent. 
Ambulatory ECG monitoring. Twenty-four hour ECG 
recordings were ohtaincd in all patieats 9 Z? 4 days after 
infarction and within 48 h of electrophysiologic study in the 
anriarrhythmic drug-free state. All patients underwent at 
least I week of continuous telemetry. These recordings were 
analyzed for the presence of ventricular tachycardia. 
Cardiac catheterization. Cardiac catheterization was gen- 
erally performed during the nonacute phase of myacardial 
infarction. In all patients undergoing ventriculography. this 
procedure confirmed the presence of a left ventricular aneu- 
rysm. Some patients whh suitable coronary anatomy also 
underwent coronary angioplasty at the discretion of their 
attending physician. 
Follow-up. Follow-up data were obtained by telephone 
interview with the patient or with the patient’s physician if 
the patient had an arrhythmic event or died. Sudden death 
was defined as unexpected death occurring within I h after 
the onset of symptoms. The mechanism of sudden death was 
assumed to be arrhythmic. 
Data analysis. Data were analyzed with the aid of the 
CLINFD computer resource using Fisher’s exact test for 
categorical variables and Sludent’s unpaired f test for con- 
tinuous data (two-tailed). Life table analysis was performed 
by the Kaplan-Meier method, with the Mantel-Cox test for 
the comparison of two life tables. Da:a aric cxprcssed 8s 
mean t SD. A probability value CO.05 is considered sicnif- 
icant. 
Results 
Study group. During the study period. 32 patients sus- 
tained an initial anterior wall myocardial infarction cometi- 
cated by acute left ventricular aneurysm formation. Sixteen 
patica did not receive acute thrombolytic therapy (Croup 
A) Lxause of inability to obtain informed consent (two 
patients), myocardial infarction not definitively diagnosed in 
the emergency room (two patienrs). attending physician 
refusal (three patients), conrraindications to thmmbolytic 
therapy (for example. menstruating woman or tustory oi 
recent cerebrovascular event [four patients]) and patient 
presentation more than 5 h atIer the onset of chest pain (five 
patients). Sixteen patients (Group B) received thrombolytic 
therapy within 6 h of symptom onset. Six Group B patients 
received streptokinase (intravenous in 5 and introcoronary in 
I) and IO received intravenous recombinant issue plasmi- 
uogen activator (t-PA). The mean time from the onset of 
chest pain to the administration ofthmmboiyric therapy was 
3.2 + 1.3 h (range I.5 to 5.5). 
Twenty palienrs (8 Group A. I2 Group B) mderwenr 
electrophysiologic study. The other 12 patients did not 
undergo such study because of attending physician refusal (8 
patients) or patient refusal (4 patients). Patients who did and 
did not undergo electrophysiologic study were similar with 
respect o treatment with thrombolytic agents and all clinical 
variables. 
Clinkal features (Table 1). Group A and B patients had a 
similar left ventricular ejection fraction (28 ? 9 [Group Al 
versus M + 8% [GtOUQ Bl, p = NS). prevalence of new 
bundle branch block, spo”taneOus nonsustained ventricular 
tachycardia and congestive heart failure. Patients who re- 
ceived thrombolytic therapy had a higher peak creatine 
kirwe MB level (446 + 336 versus 205 ? 120 IL]; p = 0.017) 
and dn CP-rher “eak enr”me level ,I,.4 t 6.6 h versus 19.7 + 
6.1 h: Q = O.&J, than had Group A patients. 
Catheterization results (Table 2). Coronary angiography 
and ventriculography were perforrncd 9 + IO days after 
myocardial infarction in 23 of the 32 study patients (I I in 
Group A, I? in Group 6). GmUQ B patients underwent 
curheterirvtion earher after myocordial infarction than did 
G,O”Q A patients (5 + 6 “enUs I3 + 6 days; Q = 0.011). 
Patients receiving thrombolytic therapy also had a greater 
frequency of left anterior descending coronary artery mu- 
!eucy (73 versus 9%; Q = 0.028) than did patients receiving 
routine care. An equal proportion of Group A and Group B 
patients had triple vessel coronary artery disease. 
There was i trend indicaung that mox patients who 
received thrombolytic therapy underwent coronary angio- 
plasty during their hospitalization. This was a result of the 
more frequent left anterior descending coronary artery pa- 
tency in patients receiving thrombolytic therapy. There was 
no signdicant difference between the two groups when 
coronary angioplasty and bypass grafting were considered 
together. Eighteen of the 20 patiems who underwent ekc- 
troQhysiologic study aI= underwent cardiac catheterization. 
and Ihew cntheteriwtion resuits were similar iv those in the 
FZQ not undergoing electrophysiologic study. 
Eleetrophysiolo@e study real&. Eight G~OUQ A Qatienis 
and I? G&p B p&euts underwent electraphysiologic s!udy 
ut a mean of I5 c 5 and I? r 6 days after myocardial 
infarctton. respectively Ip = NS). S WI @8%) of 8 Group A 
patents had inducible ventricular taehysardia compared 
wth only t (8%) of 12 Group B patients (p = O.ouO8) (Fig. I). 
Induced ventricular tachycardia WBE nonswnined in four 
patients (four in Group A, woe in Group B). and was 
sustained in the other four patients (three in Group A, one in 
Group 8). All sustained ventricular tachycardias were mo- 
nomorphic, No clinical descriptor other than nonreceipt of 
early thrombolytic therapy predicted ventricular tachycardia 
Group A moup B 
inductian. There was no ccrrelation between ventricular 
tachycardia induction and the length of time between myo- 
cardial infdrcticn and ekctrcphysiologic study. 
Follow-up (Table 3). During a mean follow-up period of 
II + 9 zx:hs; xxx of tk patients lreated wiib aciite 
thmmbolytic therapy has died or had an srrhythmic event 
compared with eight Group A patients (50%) who either died 
suddenly (seven patients. four with documented ventricular 
fibrillation and one with sustained ventricular tachycardia) 
or were resuscitated from sustained ventricular tacbycardia 
(one patient) (p = 0.002). Despite the similarly depressed left 
ventricular function in patients in Groups A and B, there 
were cc deaths due to congestive heart failure during the 
follow-up period. 
When follmtv~p was nnnlyeed according to clecrrophys- 
iolngic rrudy rrsalrs (Ff,q. 2). the 8 patients with inducible 
ventricular tachycardia had a significantly wcrsc cutccme 
compared with rhat in the I2 patients without inducible 
ventricular tachycardia (4 patients [SO%] had clinical 
arhythmic events compared with none of 12 patients with- 
cut inducible ventricular tachycardia Ip = 0.021). Of the four 
patients with an anhythmic event, two had inducible non- 
sustained ventricular tachycardin and twc had inducible 
sustained ventricular tachycardia. At the time of their clini- 
cui arrbylbmic event, rbese four puirnih wem treated -with 
an antiarrhythmic agent that did not completely suppress 
ventricular tachycardia induction during electrcphvsiologic 
study (one patient each receiving tocainide, amiodaror,L. 
phenytoin and procainamide). The four patients who did not 
Table 3. Outcome of All 32 Patients Bared an Receipt of 
Thrcmholytic Therapy 
undergo electmphysiologic study and died suddenly were 
not treated with an antiarrhythmic agent. 
Discussion 
Beneficial antiarrhythmic etfecls of thrombolytic therapy. 
This pmspective study demonstrates that patients with an 
anterior wall mywardial infarction complicated by left ven- 
tricular aneurysm formation who are treated early with a 
thmmbolytic agent (Group B) have improved arrhythmia- 
free survival and electrical stability corncared with wtients 
receiving routine care (Group A). These bea&eiai elfects of 
thmmbolytic !beia.w were observed despite a lath. of im- 
provement in global left ventricular ej&cn fraction or in 
clinical variables normally associated with a poor prognosis. 
The mortality rate in the group receiving routine care is 
smular to that seen in other studies (6.1) of patients with left 
venlricular aneurysm formation alter transmural anterior 
myocardial infarction. Thus the difference in the mortality 
rate between patients in Groups A and B is due to the 
improved outcome of patients in Group B (the patients 
receiving thrcmbolytic therapy). Furthermore. it is unlikely 
F&xc 2. Life t&de an&& of the cumulative proportion of pl- 
tients surviving wbhaut sudden cardiac death (SCD) or clinical 
sustained venlricular lachycardia WJS VT) based on the induction 
of ventricular lachyca dia Wn during eleotrophysiolotdc study. 
that the treatment of some Group A piltients with a” anti- 
arrhythmic agent was responsible for their poorer outcome. 
Only half of Group A patients with a” arrhythmic event 
received antiarrhythmic therapy, there was no significant 
correlation between outcome and treatment with an anti- 
arrhythmic agent and no proarrhythmic effects were see” 
with the aotiarrhythmic agents during clcctrophysiologic 
study and ambulatory electrocardiographic monitoring. 
Induction of venrriculor lochycardia was of prngnork 
significance in the subgroup of potiems undergoing CIFC- 
troohvsioloeic studv. It oredicted future sudden cardiac 
de&h or c&d s&taineh ventrrcular tachycardia with a 
sensitivity of IGil% and a specificity of 75%. Thus. most 
patients who received routine care. but not those recewing 
thrombolytic therapy, demonstrated a” unstable electrical 
milieu during electrophysiologic testing early after myocar- 
dial infarction. The clinical outcome of the entire studv 
group supports this view 
This study was not designed IO demonstrate vhelher 
patients receivirg thrombolyrk rhempy hod nwre repe& 
sion. Clearly, any reperfusion that occurred in Group B 
patients was not sufficient o prevent a large anterior myo- 
cardial infarction with aneurysm formation. Group B pa- 
tieruts, however, had both significantly higher peak creatine 
kinase MB fraction values and an earlier time from the ““set 
ofchest pain to these peak values than did Group A patients. 
These results are consistent with the occurrence of rep&u- 
sion in Group B patients (9,lO). Group B patients, who 
underwent catheterization earlier than did patients not given 
thrombolytic therapy. tds” had a significantly greater fie- 
qoency of left anterior descending coronary ortery patency. 
Together these results suggest hat the majority of patients 
treated with a thrombolytic agent had repertusion. although 
it may have been late or incomplete. 
Comparison with other studies. Other investigators (Ii- 
Ig) performing e!ectrophysiologic studies after myocardial 
infarction in patients without clinical sustained ventricular 
arrhythmias have repotted induced ventricular tachycardia 
in I7 to 46% of patients. Their conclusions reaarding the 
prognostic value if this finding have varied, pT”babl; be- 
cause of differences in patient groups, study design. fol- 
low-up periods and electrophysiologic studg stimulation 
protocols. The present investigation is not directly cornpa- 
rahle with these other studies because this is the first study 
to focus on a specific, homogeneous, high risk group of 
patients. Our results are. however, consistent with those of 
studies (12.13) examining other groups of patients with 
complicated myoardial infarction (congestive heart failure 
or bundle branch block). Kerrschot et al. (181 observed that 
patients treated with streptokinase have inducible ventricu- 
lar tachycardia less frequently than do patients receiving 
routine care. but they related this to differences in infarct 
size. Because they studied a relatively low risk group I:! 
patients with no deaths during the follow-up period. the i 
were xahle to dem”nstro!r a predictive value of electrophy- 
siologlc study after infarction. 
Mechanisms. The mechanisms responsible for the bene- 
ficial cffccts of thrombolytic therapy a” electrical stability in 
Gmup B patients are unknown. Mapping of ventricular 
tachycardia in animals (19) and humans (20.21) with myo- 
cardml infarction has show” that the reentrant circuit is 
located in the sndh-ardial border zone of diseased myocar- 
dium between the infarct scar and normal tissue. Thus. the 
most plusible mechanism for our findings is that reperfusion 
af the left anterior descending coronary artery caused 
changes in this border zone. with possible mechanisms 
lncludine salvaee of border zone mvocardial cells. alter- 
aU”ns ihtheir e~ectrophysiologic char&zteristics. changes in 
remodclina of the infarction makine. the establishment of a 
f”nctio”aiarhythmic circuit ““likely or alterations in wall 
stress as a result of changes in diastolic expansion. Hochman 
and Choo (22) recently showed that reprfusion that does not 
occur early enough to result in myocardial salvage can have 
considerable ffects on postinfarction remodeling in the rat. 
W&r et al. (23) recently described the frequent occurrence 
of hemorrhaic infarction only in the heart of patients treated 
with thromh~lytic agents. Hkmorrhage r&cause destroc- 
tion of the border zone or alter myocardisl architecture in 
such a way that arrhythmic circuits do not form. 
Limitations of study. We prospectively examined a well 
defined homogeneous cohort of patients. and it is possible 
that “or results are not fully applicable to other groups of 
patienta, particularly those with uncomplicated myocardial 
infarction. This study was prospective, but patients were not 
randomized to treatment with thrombolytic therapy. Be- 
caose resent evidence (1.4.5) demonstrates that thromboly- 
tic therapy improves survival in patients with anterior myo- 
cardial infarction, withholding such therapy for research 
purposes would be unethical. 
The sample size is small. and thus some caution needs to 
be exercised in interpreting the results. Although it was 
possible to perform electrophysiologic studies in only 20 of 
the 32 eligible patients. the patients who underwent elec- 
trophyriologic study are representative of the entire study 
group. There was a trend toward more frequent coronary 
angioplasty in patients who received thrombolytic therapy. 
reflecting the greater prevalence of left anterior descending 
coronary anery patency in these patients. It is w!ike!y that 
this trend accounts for the improved survival in patients in 
Group B because coronary angioplasty was performed only 
in patients whose lel? anterior descending coronary at’tet’y 
was already patent and less than half ofthz Group B patients 
underwent coronary angioplasty. Furthermore. angioplasty 
was not significantly associated with inducibility of ventri- 
cular tachycardia or survival. It is possible that with a larger 
group of study patients. significant clinical contributors to 
the poorer survival rate and increased inducibility of 
arrhythmia in patients not receiving thrombolytic therapy 
might be identified. This would not. however, alter the 
conclusion that patients treated with thmmbolytic therapy 
who nevertheless develop a left ventricular aneurysm man- 
ifest greater electrical stability then do those who do not 
receive thmmbolytic therapy. Clinical di5crences would 
offer additional explanations for this effect. 
Conclusions. Despite the occurrence of a large tran- 
smural anterior myocardial infarction complicated by left 
ventricular aneurysm formation. thrombolytic therapy sig- 
nificantly improved outcome and electrical stability indepen- 
dent of global myocardial salvage in the study group. Fur- 
thermore, electraphysiologic studies were of prognostic 
value in this high risk group of patients. Aggressive diagnos- 
tic and trcament modes, including electrophysiologic study 
and optimal pharmacologic and nonpharmacologic anti- 
arrhythmic therapy, need to be explored for patients not 
receiving thrombolytic therapy who develop an acute left 
ventricular aneurysm after anterior myocardial infarction. 
